FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease.

Trends Cardiovasc Med

Heart & Vascular Institute, Lenox Hill Hospital, Department of Cardiology, Northwell Health System, Hofstra Northwell School of Medicine, New York, NY. Electronic address:

Published: November 2016

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been extensively used worldwide for both chronic and acute musculoskeletal and inflammatory conditions. Extensive evidence has linked NSAID use with adverse cardiovascular events. This review article aims to review the existing evidence on the risk of cardiovascular and coronary events in both selective and nonselective NSAIDs, the time course of NSAIDs associated with cardiovascular risk, and specific populations that may be at increased risk.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tcm.2016.04.011DOI Listing

Publication Analysis

Top Keywords

nonsteroidal anti-inflammatory
8
anti-inflammatory drugs
8
fda labeling
4
nsaids
4
labeling nsaids
4
nsaids review
4
review nonsteroidal
4
cardiovascular
4
drugs cardiovascular
4
cardiovascular disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!